Combined administration of anti‐IL‐13 and anti‐IL‐17A at individually sub‐therapeutic doses limits asthma‐like symptoms in a mouse model of Th2/Th17 high asthma
Kim, Dasom, McAlees, Jaclyn W., Bischoff, Lindsay J., Kaur, Davinder, Houshel, Lauren K., Gray, Jerilyn, Hargis, Julie, Davis, Xenia, Dudas, Paul L., Deshmukh, Hitesh, Lewkowich, Ian P.
Published in Clinical and experimental allergy (01.03.2019)
Published in Clinical and experimental allergy (01.03.2019)
Get full text
Journal Article